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Excitatory synaptic transmission is modulated by
inhibitory neurotransmitters and neuromodulators.
We found that the synaptic transmission of somatic
sensory afferents can be rapidly regulated by
a presynaptically secreted protein, follistatin-like 1
(FSTL1), which serves as a direct activator of
Na+,K+-ATPase (NKA). The FSTL1 protein is highly
expressed in small-diameter neurons of the dorsal
root ganglion (DRG). It is transported to axon termi-
nals via small translucent vesicles and secreted in
both spontaneous and depolarization-induced man-
ners. Biochemical assays showed that FSTL1 binds
to the a1 subunit of NKA and elevates NKA activity.
Extracellular FSTL1 induced membrane hyperpolar-
ization in cultured cells and inhibited afferent
synaptic transmission in spinal cord slices by acti-
vating NKA. Genetic deletion of FSTL1 in small
DRG neurons of mice resulted in enhanced afferent
synaptic transmission and sensory hypersensitivity,
which could be reduced by intrathecally applied
FSTL1 protein. Thus, FSTL1-dependent activation
of NKA regulates the threshold of somatic sensation.
INTRODUCTION
Theefficacyof synaptic transmission ismodulatedby thepresyn-
aptic actions of neurotransmitters and neuromodulators (Engel-
man and MacDermott, 2004; Hyman, 2005), which regulate the
presynaptic release of neurotransmitters by binding to specific
membrane receptors (Hyman, 2005). Small-diameter neurons in
the dorsal root ganglion (DRG) give rise to unmyelinated axons
(C-fibers) and thinly myelinated axons (Ad-fibers) that terminate
in laminae I–II of the spinal cord. These axons convey the somatic974 Neuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc.sensory signals generated by nociceptors, thermoreceptors, and
sensitive mechanoreceptors (Maxwell and Rethelyi, 1987; Woolf
andMa, 2007). In response to peripheral stimulation, these axons
release glutamate and neuropeptides, substance P (SP), and
calcitonin gene-related peptide (CGRP) via exocytosis of
synaptic vesicles and large dense-core vesicles (LDCVs). This
excitatory synaptic transmission is modulated by the inhibitory
neurotransmitter g-aminobutyric acid and opioid peptides
secretedby spinal interneurons. Thepresent studydemonstrates
a regulatory system that consists of the follistatin-like 1 (FSTL1)
protein secreted from afferent axons and its presynaptic
receptor, the a1 subunit of Na+,K+-ATPase (NKA) (Kaplan, 2002).
The glycoprotein FSTL1 was initially discovered when
previous investigators found that FSTL1 could be induced by
transforming growth factor-b1 (Shibanuma et al., 1993; Zwijsen
et al., 1994). FSTL1 is one of the secreted proteins rich in
cysteine (SPARC) that contain one follistatin-like domain and
a pair of EF-hands (Grabarek, 2006). FSTL1 belongs to
a subfamily of the follistatin gene family (Brekken and Sage,
2000; Hambrock et al., 2004), but does not bind to activin.
FSTL1 has been shown to reduce the growth of cancer cells
(Mashimo et al., 1997; Sumitomo et al., 2000), act as an Akt
protein kinase-regulated cardioprotective factor in the heart
(Oshima et al., 2008), and serve as a target protein for autoanti-
bodies in human rheumatoid arthritis (Tanaka et al., 1998, 2003).
However, the receptor for FSTL1 in the body was not identified.
Additionally, FSTL1 was found to be expressed in the nervous
system (De Groot et al., 2000; Malik-Hall et al., 2003), but the
neuronal function of FSTL1was unknown. In this study, we found
high levels of FSTL1 in small DRG neurons. Surprisingly, unlike
neuropeptides and brain-derived neurotrophic factor, which
are secreted via LDCVs (Salio et al., 2005), we observed that
FSTL1 is transported to axon terminals via small translucent
vesicles and secreted in a manner similar to neurotransmitters.
We further found that FSTL1 directly activates a1 subunit-con-
tainingNKA (a1NKA).NKA, also knownasanNa+-K+pump, trans-
ports three Na+ out of cell and two K+ into cell, thereby playing
a crucial role in maintaining the Na+ and K+ gradient across the
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resting membrane potential and excitable properties of neurons
(Hamada et al., 2003; Kaplan, 2002; Morth et al., 2007; Takeuchi
et al., 2008). NKA activity is regulated by direct modulators
(ATP, Na+, K+, and cardiotonic steroid inhibitors ouabain and
digoxin) and indirect modulators (catecholamines, insulin, angio-
tensin II, and morphine) through receptor-mediated mechanisms
(Therien and Blostein, 2000). NKA is a heterodimer composed of
one a subunit and one b subunit. The catalytic, transport, and
pharmacological properties of NKA reside in the a subunit, while
the b subunit is involved in cell surface delivery and appropriate
insertion of the a subunit. Four isoforms of a subunits (a1–a4)
and three isoformsof b subunits (b1–b3) are expressed in a tissue-
and cell-dependent pattern. It was unknown whether NKA could
be regulated by endogenous agonists.
The mRNAs for NKA a1, a3, and b1 subunits were found in the
DRG (Fink et al., 1995; Hamada et al., 2003; Mata et al., 1991).
The a1 subunit is expressed in both small- and large-diameter
DRG neurons, whereas the a3 subunit is mainly distributed in
large ones (Dobretsov et al., 1999a, 1999b). Electrophysiology
showed that the membrane current produced by NKA activity
in DRG neurons was primarily mediated by a1NKA (Hamada
et al., 2003; Mata et al., 1991). Reduction in NKA activity in the
peripheral nerve was found to be partly responsible for diabetic
neuropathy, which presents sensory symptoms such as pares-
thesias and pain (Krishnan and Kiernan, 2005; Vague et al.,
2004). We identified FSTL1 as an a1NKA agonist that
suppresses synaptic transmission and maintains the normal
threshold of somatic sensation. This finding revealed an
agonist-dependent mechanism for activating the Na+-K+ pump
and provided further insight about the pump’s physiological role.
RESULTS
FSTL1 Is Highly Expressed in DRG Neurons
In an attempt to identify novel functional molecules in DRG
neurons, we searched for genes expressed at high levels in the
DRGbut at low levels in other tissues.Utilizing twoavailable data-
bases (see Supplemental Experimental Procedures), we found
71 candidate genes and verified their expression patterns with
a microarray (Figure S1, available online). Fstl1 was one of the
genes with the highest expression level in the DRG of adult rats
(Figure S1 and Tables S1–S3). Both northern blotting (Figure 1A)
and immunoblotting (Figure 1B) with specific FSTL1 antibodies
(Figure S2A) confirmed the abundant expression of FSTL1 in
the DRG. Low levels of FSTL1 were also present in heart, lung,
brain, kidney, and muscle (Figure S1). Immunostaining showed
that FSTL1 was enriched in DRG (Figure 1C) and trigeminal
ganglion (Figure S2B) neurons of both rats andmice. In the brain,
FSTL1 was found in the mesencephalic trigeminal nucleus, the
red nucleus, and the oculomotor nucleus (Figure S2B).
In rat DRGs, FSTL1was expressed in60%of small neurons at
high levels and in10%of large neurons at low levels (Figure 1C).
Small neurons consist of peptidergic neurons, e.g., those contain-
ing CGRP and SP, and nonpeptidergic neurons, which bind iso-
lectin B4 (IB4). Approximately 54% of FSTL1-positive small
neurons contained CGRP, while 45% were labeled by IB4 (Fig-
ure 1D). Approximately 89% of CGRP-positive neurons and55% of IB4-positive neurons expressed FSTL1. The FSTL1-
positive neurons contained the vanilloid receptor type 1 (TRPV1)
(56%) and the Nav1.8 channel (90%) (Figure 1D). In laminae
I–II of the spinal cord, FSTL1 was seen in most CGRP-positive
afferents (Figure 1E) and some IB4-positive ones. However,
FSTL1 labeling in axons was weaker than the labeling in the cell
body. Weak FSTL1 labeling was also seen in some afferent fibers
in laminae III–IV. Thus, FSTL1 is synthesized in the cell body of
DRG neurons and transported to their axon terminals.
FSTL1 Is Transported via Small Translucent Vesicles
Synaptic vesicles and LDCVs in axon terminals release their
contents in response to stimulus-induced elevation of intracel-
lular Ca2+ ([Ca2+]i). Synaptic vesicles are then recycled in axon
terminals, while LDCVs have to be generated in the cell body.
Double immunostaining showed that FSTL1 was localized in
vesicles that contained neither CGRP nor SP (Figure 1F) in small
DRG neurons. These FSTL1 vesicles were also seen in IB4-posi-
tive neurons (Figure 1F). Postembedding immunogold labeling
showed that FSTL1 was localized to small translucent vesicles
(30–80 nm in diameter) near the trans-Golgi network (TGN) and
in the afferent axons of dorsal roots (Figure 2A). In spinal lamina
II, FSTL1 vesicles were observed in the afferent terminals identi-
fied as the central terminal of glomeruli and sometimes in the
presynaptic active zone (Figure 2A). Moreover, pre-embedding
immunoperoxidase staining also showed the FSTL1-immunore-
active vesicles in the axonal terminals and some of these vesi-
cles near the presynaptic membrane (Figure 2B).
To confirm the morphological results, we used subcellular
fractionation with a sucrose gradient to separate different vesicle
populations in the spinal dorsal horn of rats (Figure 2C).We found
that FSTL1 mainly appeared in small vesicle fractions that con-
tained synaptoporin, a member of the synaptophysin super-
family and an integral membrane component of synaptic vesi-
cles in afferent terminals (Sun et al., 2006), but not in LDCV
fractions labeled by CGRP (Figure 2C). Thus, FSTL1 is localized
to small translucent vesicles.
The identity of FSTL1 vesicles was further analyzed in the
afferent axons of dorsal roots. Double immunostaining showed
that53% of FSTL1 vesicles (n = 2050 in 212 axon profiles) con-
tained vesicular glutamate transporter 2 (VGluT2) in the axons of
rats (Figure 2D) and mice (Figure S3A). Also, 39% of the
vesicles contained vesicle-associated membrane protein 2
(VAMP2) (n = 378 in 35 axon profiles) (Figure 2D). However,
only a small number of FSTL1 vesicles contained synaptoporin
(12%, n = 2624 in 138 axon profiles) or synapsin (14%, n =
777 in 64 axon profiles) (Figure 2D). Thus, newly synthesized
FSTL1 is mainly transported via VGluT2- and VAMP2-containing
vesicles, while only a small amount of FSTL1 is transported via
the vesicles carrying synaptoporin and synapsin (Hannah et al.,
1999; Santos et al., 2009).
Spontaneous and Depolarization-Induced
Secretion of FSTL1
We directly examined the potential secretion of FSTL1 in DRG
neurons cultured from young rats. Immunoblot analysis showed
that the level of FSTL1 in the culture medium was increased in
the absence of the stimulus (Figure 2E), indicating spontaneousNeuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc. 975
Figure 1. Expression of FSTL1 in the
Nervous System
(A) Northern blotting showed FSTL1 mRNA in the
nervous system of adult rats.
(B) Immunoblotting showed FSTL1 protein
(37 kDa) in the rat nervous system.
(C) FSTL1-immunoreactive neuronal profiles in the
DRG were mainly distributed in small neurons
(<1000 mm2). Scale bar = 100 mm.
(D) Double-immunofluorescent staining showed
that, in rat DRGs, FSTL1 was present in most
CGRP-positive neurons and colocalized with the
Nav1.8 channel. FSTL1 was also found in some
IB4-positive neurons and in most TRPV1-positive
neurons. Scale bar = 50 mm.
(E) Double staining showed that FSTL1 was
present in many CGRP-positive afferent fibers in
laminae I–II of the rat spinal cord. Scale bars =
100 mm. A high-magnification image revealed
colocalization of FSTL1 and CGRP in axon termi-
nals (arrow). Scale bars = 10 mm.
(F) The vesicular distribution of FSTL1 (arrow) was
present in both peptidergic and IB4-positive small
neurons in rat DRG. Neither CGRP nor SP was
found in FSTL1-positive vesicles (arrow). Scale
bar = 5 mm.
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by K+-induced membrane depolarization (55 mM KCl, 1 hr), but
only in the presence of extracellular Ca2+ ([Ca2+]o) (Figures 2F
and 2G). The FSTL1 level was increased by the TRPV1 channel976 Neuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc.activator, capsaicin, and that response
was abolished by the TRPV1 channel
blocker, capsaizepine (Figure 2F).
Additionally, high-K+ stimulation for
15 min enhanced FSTL1 secretion from
the spinal cord slices of rats (Figure 2H)
andmice (Figure S3B) as well as synapto-
somes prepared from the spinal dorsal
horn (Figure 2I). As expected, the secre-
tion of CGRP, SP, and glutamate was
also increased in the same preparation
(Figures 2H and 2I). The stimulus-evoked
secretion of FSTL1 from synaptosomes
occurred only in the presence of [Ca2+]o
(Figure 2I). In contrast, the spontaneous
secretion of tenascin-C, an extracellular
matrix glycoprotein (Joester and Faiss-
ner, 2001), was unaffected by the K+
stimulation (Figure 2I and Figure S3C).
Together, these results suggest that
FSTL1 is stored in small translucent vesi-
cles and can be secreted either sponta-
neously or by depolarization in a manner
similar to neurotransmitters.
FSTL1 Inhibits Synaptic
Transmission
To determine whether secreted FSTL1
plays a physiological role in the spinalcord, we performed whole-cell recording of lamina II neurons
to monitor afferent synaptic transmission in dorsal root-attached
spinal cord slices from rats (Nakatsuka et al., 2000). We trans-
fected the plasmid-expressing rat FSTL1 fused with myc and
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fied the resulting recombinant FSTL1 protein (Figure 3A and
Figure S3D). The secreted form of recombinant FSTL1 was gly-
cosylated and had a molecular mass of 37–45 kDa (Fig-
ure S3D). Deglycosylated FSTL1 had a molecular weight of
34 kDa (Figure S3D).
Recombinant glycosylated FSTL1 was used to examine the
effect of exogenous FSTL1 on synaptic transmission between
afferent terminals and local neurons in lamina II (substantia gelat-
inosa), a translucent band in the superficial dorsal horn. We
found that among 50% (16/31) of recorded neurons, applica-
tion of FSTL1 (60 or 300 nM) resulted in a reduction of more
than 10% in the mean frequency or mean amplitude of sponta-
neous excitatory postsynaptic currents (sEPSCs) (Figure 3B).
Similar application of FSTL1 also reduced the amplitude of
C-fiber stimulation evoked EPSCs (eEPSCs), which were
present in 50% (12/24) of recorded monosynaptic neurons
(Figures 3C and 3D). A similar inhibitory effect of FSTL1
(60 nM) was found in polysynaptic neurons (Figure S3E). Further
studies of miniature EPSCs (mEPSCs) in the presence of tetro-
dotoxin (0.5 mM) showed that FSTL1 also reduced the frequency,
but not the amplitude, of mEPSCs (Figure 3E), suggesting that
there is presynaptic suppression of glutamate release by
FSTL1. The decay kinetics of eEPSCs were unaffected by
FSTL1 (Figure 3D), indicating that FSTL1 had no direct effect
on postsynaptic glutamate receptor channel properties.
Together, these results suggest that FSTL1 acts presynaptically
on neurotransmitter release, rather than postsynaptically on
glutamate responses. In addition, for neurons that showed
FSTL1-induced eEPSC reduction, the synaptic delay after
C-fiber stimulation was reversibly increased (Figure 3C), sug-
gesting a presynaptic reduction of excitation-secretion coupling
and/or impeded action potential (AP) propagation in the C-fiber.
Finally, the specificity of FSTL1 function was indicated by the
lack of synaptic suppression effects of follistatin or two mutated
forms of FSTL1 that either have a pair of EF-hands deleted
(FSTL1DEF) or a loss-of-function mutation at the Ca2+-binding
site Glu165 (FSTL1E165A), which is conserved across species
(Figures 3C and 3E and Figures S3F and S3G). Thus, exogenous
FSTL1 suppresses afferent synaptic transmission in the dorsal
horn through presynaptic inhibition.
FSTL1 Binds to the a1 Subunit of NKA
How does FSTL1 act on presynaptic nerve terminals? To identify
the protein’s membrane target, we used the membrane-imper-
meant bifunctional reagent bis[sulfosuccinimidyl] suberate
(BS3) to chemically crosslink recombinant FSTL1 with myc and
His tags to components present on the surface of cultured rat
DRG neurons. The cell lysate was analyzed by an immunoblot
with myc antibodies. An immunoreactive band with a molecular
weight of 140 kDa, which is much larger than the expected
mass of recombinant FSTL1 (37–45 kDa, depending on the
glycosylation status), appeared when cells were crosslinked
with FSTL1 (Figure 4A), suggesting that FSTL1 associates with
a membrane protein that has a molecular weight of 100 kDa.
The crosslinked proteins were purified and analyzed by mass
spectrometry (MS). In addition to the peptide sequences of
FSTL1, 3–7 peptides matched the a1 subunit of NKA. The datafrom three samples represented 15% coverage of the a1 subunit
sequence. This result was confirmed by an immunoblot of DRG
cell lysates with a1 subunit antibodies that showed the cross-
linked protein at 140 kDa, in addition to the predicted a1
subunit (100 kDa, Figure 4B) (Nishi et al., 1999). In contrast,
immunoblotting for the a3 subunit (110 kDa) (Nishi et al.,
1999) in the same lysate showed no crosslinked proteins at
higher molecular weights (Figure 4B), indicating a specific
FSTL1 interaction with the a1, but not the a3 subunit (Dobretsov
et al., 1999b; Hamada et al., 2003).
In situ hybridization (Figure S4A) and immunostaining (Fig-
ure 4C) showed that the a1 subunit was expressed in 51% of
rodent DRG neurons. Of the neurons,63%were small neurons
and FSTL1 was also expressed in 66% of a1 subunit-contain-
ing neurons (Figure 4C). Coimmunoprecipitation (co-IP) studies
showed an interaction between the NKA a1 subunit and FSTL1
in rat DRG extracts (Figure 4D). Furthermore, we cotransfected
the plasmids expressing the a1 subunit and FSTL1 or its mutant
into COS7 cells in which FSTL1 was absent and the endogenous
a1 subunit was expressed at a low level (8% of the expression
in DRG) (Figure S4B). We found that the a1 subunit interacted
with FSTL1 (Figure 4E), but not with the loss-of-function mutant
FSTL1E165A and FSTL1DEF (Figures S4C and S4D).
Furthermore, an equilibrium binding assay showed that
125I-FSTL1 exhibited dose-dependent binding to COS7 cells
expressing exogenous a1 and b1 subunits (Figure 4F). The assay
yielded an apparent dissociation constant (KD) of 43 nM, indi-
cating the presence of high-affinity binding. Consistent with the
requirement of both a1 and b1 subunits for functional assembly
of NKA and the involvement of the b subunit in cell surface
delivery and appropriate insertion of the a subunit (Kaplan,
2002), we found that 125I-FSTL1 did not bind to cells expressing
only the a1 or b1 subunit (data not shown). 125I-FSTL1 also did
not specifically bind to the cells expressing a3 and b1 subunits
(Figure 4F) or the cells transfected with the pIRES-EGFP plasmid
(data not shown). Together, these results indicate that FSTL1
directly binds to the a1 subunit of NKA.
Identification of Interaction Domains in the a1 Subunit
The a subunit has ten transmembrane segments (M1–M10) and
five extracellular loops (ELs M1M2, M3M4, M5M6, M7M8, and
M9M10), while both termini are intracellular (Kaplan, 2002; Morth
et al., 2007). To search the FSTL1-binding domain in the a1
subunit, we synthesized peptides corresponding to each of the
fivepredictedextracellular loopsand thenperformed theBIAcore
analysis.Weobserved the binding of FSTL1 to theM3M4peptide
(equilibrium KD: 258 mM) and the M7M8 peptide (KD: 53 mM)
(Figure 4G), while the M1M2 peptide had a low-binding affinity
(KD: 72 mM). There was no detectable binding for M5M6 and
M9M10 peptides. Thus, the M3M4 and M7M8 ELs might be
involved in the interaction with FSTL1 (Figure 4G).We then deter-
mined the binding sites in transfected COS7 cells by examining
the interaction between FSTL1 and a FLAG-tagged a1 subunit
with a point mutation at various sites in theM3M4 orM7M8 loops
that differ from the a3 subunit. We found that Gly substitution of
Glu314 in M3M4 or Asn substitution of Thr889 in M7M8 reduced
the level of FSTL1 in the IPofFLAG-taggeda1subunit (Figure4H),
whereas Glu888 to Leu or Trp893 to Thr mutation in M7M8 had noNeuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc. 977
Figure 2. FSTL1 Is Secreted via Small Translucent Vesicles
(A) Immunogold labeling of FSTL1 was associated with small vesicles (arrow) near the trans-Golgi network (TGN) in the cell body of small DRG neurons and with
small translucent vesicles (arrow) in both afferent axons and the central afferent terminal in a glomerulus in spinal lamina II of the rat. A FSTL1-positive vesicle
(arrow) was located near the presynaptic membrane. The arrowhead indicates the postsynaptic density. Scale bar = 100 nm.
(B) Pre-embedding immunoperoxidase staining showed that in an axonal terminal in spinal lamina II, a proportion of small vesicle contained FSTL1 immunore-
activity (arrows) in the section that was not counterstained. Thin arrows point to examples of unlabeled small vesicles. Arrowhead indicates the postsynaptic
density. Scale bar = 100 nm.
(C) Immunoblotting of equal volume aliquots of the supernatant fractions from rat spinal dorsal horn showed that FSTL1 was present in synaptoporin-containing
fractions, but not in CGRP-containing fractions. This image represents three experiments.
(D) Double immunostaining of rat dorsal roots showed that most FSTL1-positive vesicles in the afferent axons contained VGluT2 and VAMP2, but neither
synaptoporin nor synapsin. Scale bar = 5 mm.
(E) Immunoblotting showed that in the culture medium of rat DRG neurons, the FSTL1 level increased with incubation time. The immunoblot intensity of secreted
FSTL1 was normalized to whole-cell lysate (*p < 0.05, **p < 0.01 versus control, n = 3). Data shown are mean ± SEM.
(F) High-K+ treatment (55 mM KCl, 1 hr) increased the level of secreted FSTL1. Capsaicin (Cap; 1 mM, 1 hr) treatment also elevated the level of secreted FSTL1.
This effect was attenuated by capsaizepine (CPZ; 10 mM) (**p < 0.01 versus control; ## p < 0.01, n = 3). Data shown are mean ± SEM.
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Figure 3. FSTL1 Inhibits Synaptic Trans-
mission
(A) Diagrams show the recombinant rat FSTL1 and
FSTL1 mutants with an EF-hand deletion
(FSTL1DEF) or a point mutation at E165
(FSTL1E165A), fused with myc and His tags at the
C-terminal end.
(B) Whole-cell recording in a rat spinal slice was
carried out in 31 lamina II neurons that exhibited
sEPSCs at a holding potential (VH) of 70 mV. In
16 neurons, recombinant FSTL1 reduced both
sEPSC frequency and amplitude. Data collected
during the 3 min FSTL1 perfusion were quantita-
tively analyzed (*p < 0.05; **p < 0.01 versus
control). Data shown are mean ± SEM.
(C) The glutamatergic monosynaptic eEPSCs of
C-fibers, with mean amplitude of 166 ± 23 pA
(37–459 pA; VH = 70 mV), were induced by stim-
ulating the dorsal root at 0.2 Hz (strength: 210–650
mA). In 24 recorded lamina II neurons, the mono-
synaptic EPSCs evoked by C-fiber stimulation
were inhibited by FSTL1 (60 nM, n = 12; 300 nM,
n = 5), but not by FSTL1DEF (n = 5) or FSTL1E165A
(n = 5). The eEPSC latency was increased after
FSTL1 treatment (n = 10). An averaged trace
(five sweeps) from a single neuron is shown.
The eEPSC latency is the time of stimulation to
the point of 30% of peak amplitude (*p < 0.05;
**p < 0.01 versus control). Data shown are
mean ± SEM.
(D) An example of whole-cell recording in a rat
spinal cord slice where FSTL1 inhibited the
EPSC in lamina II neurons evoked by C-fiber stim-
ulation. The decay time constant of the sup-
pressed eEPSCs was not apparently altered
when it was normalized to the peak level of the
control eEPSCs. Data shown are mean ± SEM.
(E) FSTL1 (60 nM) only reduced the mEPSC
frequency in lamina II neurons (n = 15). Neither
FSTL1DEF (n = 8) nor FSTL1E165A (n = 8) affected
the mEPSC (**p < 0.01 versus control).
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subunit (Figure S4E). Furthermore, a significant co-IP signal
was observed when we expressed a FLAG-tagged a3 subunit
containing a Glu substitution of Gly304 and Thr substitution of
Asn879 (Figure 4H). Thus, Glu314 and Thr889 in the NKA a1 subunit
are critical for FSTL1-binding (Figure 4I).
FSTL1 Activates NKA
The functional consequence of FSTL1 binding to the a1 subunit
was directly shown by the dose-dependent activation of the NKA(G) The K+-induced secretion of FSTL1 was attenuated when extracellular Ca2+ ([C
0.05 versus control; #p < 0.05, n = 4). Data shown are mean ± SEM.
(H, I) Treatment with KCl (55mM, 15min) elevated the FSTL1 level in the buffer incu
spinal dorsal horn (n = 4) (I) in the presence of extracellular Ca2+ ([Ca2+]o). (I) The K
+
was found with the immunoassay, the radioimmunoassay, and the HPLC method
(*p < 0.05; **p < 0.01; ***p < 0.001 versus control). Data shown are mean ± SEMenzyme with recombinant FSTL1 in cultured DRG neurons
(EC50 = 28.6 nM, Figure 5A). Consistent with a1-specific binding
between FSTL1 and NKA, we found that the NKA activity was
dose dependently elevated by FSTL1 in COS7 cells expressing
a1 and b1 subunits (EC50 = 28.0 nM, Figure 5A), but not in cells
expressing a3 and b1 subunits, a1E314G and b1 subunits, or
a1T889N and b1 subunits (Figures 5A and 5B). The loss-of-func-
tion mutant FSTL1E165A and FSTL1DEF had no effect on the
NKA activity of COS7 cells expressing a1 and b1 subunits (Fig-
ure 5B). The effect of FSTL1 was further analyzed with the NKAa2+]o) was absent, whereas the basal secretion of FSTL1 was unaffected (*p <
bating the rat spinal cord slice (n = 3) (H) or the synaptosomes isolated from the
-enhanced secretion of CGRP, SP, and glutamate (Glu) from the synaptosomes
s, respectively. However, high K+ did not increase the secretion of tenascin-C
.
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Figure 4. FSTL1 Binds to the a1 Subunit
of NKA
(A) Immunoblotting of cultured rat DRG neurons
crosslinked with BS3 in the presence of recombi-
nant FSTL1 with myc and His tags and probed
with myc antibodies shows the FSTL1 adduct at
140 kDa (star). The immunoblot shown is a repre-
sentative of three such experiments.
(B) The same sample probed with a monoclonal
antibody against the a1 subunit of NKA showed
an increase in molecular weight from 100 kDa
to 140 kDa. There was no size shift in the a3
subunit immunoblot. Three independent experi-
ments were performed with similar results.
(C) Double immunostaining showed that the a1
subunit is colocalized with FSTL1 in many rat
DRG neurons. The a1 subunit-positive neurons
are primarily small neurons (<1,000 mm2). Scale
bar = 50 mm.
(D) Co-IP showed the a1 subunit (100 kDa) in
FSTL1-antibody-precipitated proteins from rat
DRGs. Three independent experiments were
performed with similar results.
(E) In the lysate of COS7 cells cotransfected with
plasmids expressing a1 subunit-FLAG and
FSTL1-myc, FSTL1-myc (40 kDa) was found in
proteins precipitated with FLAG antibodies. Three
independent experiments were performed with
similar results.
(F) A Scatchard plot showed that 125I-FSTL1 dose
dependently bound to the COS7 cells expressing
a1 and b1 subunits (KD: 43 nM), but not to the
cells expressing a3 and b1 subunits. Data shown
are mean ± SEM.
(G) BIAcore analysis showed that the synthetic
peptides corresponding to the predicted extracel-
lular loop (EL) M3M4 (KD: 258 mM) and M7M8
(KD: 53.4 mM) of the a1 subunit could bind to
the immobilized FSTL1 protein, while the M1M2
peptide bound to FSTL1 with a low affinity
(KD: 71.8 mM).
(H) In the lysate of COS7 cells that express FSTL1-
myc and a1 subunit-FLAG, FSTL1-myc is present
in proteins precipitated with FLAG antibodies.
The Co-IP signal of FSTL1-myc was decreased
in cells coexpressing FSTL1-myc with a1 sub-
unitE314G-FLAG, a1 subunitT889N-FLAG, or a1 sub-
unitE314G, T889N-FLAG. FSTL1-myc did not interact
with a3 subunit-FLAG but interacted with a3 sub-
unitG304E, N879T-FLAG. The immunoblots shown
are representatives of three such experiments.
(I) The localization of E314 and T889 was mapped
onto a homologymodel of the a1 subunit based on
the PDB 3B8E structure (Morth et al., 2007),
viewed from the extracellular surface (top) and
the membrane plane.
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activity was apparently increased 1 min after the treatment
with FSTL1 (60 nM) and reached a peak level at 3min (Figure 5C).
Consistent with the enzymatic activity assay, whole-cell
recording showed that bath-applied FSTL1 induced hyperpolar-
ization (6.8 ± 1.7 mV, n = 12) of COS7 cells expressing a1 and b1
subunits, but not cells expressing a3 and b1 subunits (0.6 ±
0.4 mV, n = 8) (Figure 5D).980 Neuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc.Furthermore, the M3M4 or M7M8 peptides could serve as
blockers for FSTL1 interaction with a1NKA, as shown by our
findings that the binding of 125I-FSTL1 to a1 and b1 subunit-
expressing COS7 cells was attenuated by either the M3M4
(EC50 = 3.6 mM) or the M7M8 peptide (EC50 = 2.9 mM) (Figure 5E),
but not by other EL peptides (Figure 5E and Figure S4F). The
FSTL1-induced elevation of NKA enzyme activity was similarly
blocked by these two peptides (Figure 5F). Taken together, these
Figure 5. FSTL1 Activates a1 NKA to Inhibit
Neuronal Excitability
(A) FSTL1 dose dependently elevated NKA activity
in cultured rat DRG neurons and COS7 cells co-
transfected with plasmids expressing a1 subunit-
FLAG and b1 subunit-myc. FSTL1 did not alter
NKA activity in COS7 cells expressing a3
subunit-FLAG and b1 subunit-myc. Data shown
are mean ± SEM.
(B) FSTL1 did not alter NKA activity in COS7 cells
expressing a1 subunitE314G-FLAG, a1 subu-
nitT889N-FLAG, or a1 subunitE314G, T889N-FLAG
with b1 subunit-myc. The NKA activity was not
elevated by FSTL1E165A and FSTL1DEF (*p < 0.05;
**p < 0.01 versus FSTL1-enhanced NKA activity
in a1 and b1 subunit-expressing cells, n = 4–6).
Data shown are mean ± SEM.
(C) The activity of the NKA purified from the dorsal
spinal cord of rats was significantly increased
1 min after FSTL1 (60 nM) treatment, and reached
a peak level at 3 min (*p < 0.05; **p < 0.01 versus
the control, n = 3). Data shown are mean ± SEM.
(D) FSTL1 (30 nM) induced membrane hyperpolar-
ization in COS7 cells expressing a1 and b1
subunits (n = 15), but neither untransfected cells
(n = 12) nor cells expressing a3 and b1 subunits
(n = 8) displayed hyperpolarizations (**p < 0.01
versus control). MP, membrane potential. Data
shown are mean ± SEM.
(E) 125I-FSTL1-binding in COS7 cells expressing
a1 and b1 subunits could be attenuated by prein-
cubation with M3M4 (EC50 = 3.6 mM) or M7M8
(EC50 = 2.9 mM) peptide, but not M1M2 peptide
(n = 3). Data shown are mean ± SEM.
(F) Preincubation with M3M4 or M7M8 peptide
attenuated the FSTL1-facilitated NKA activity in
a1 and b1 subunit-expressing COS7 cells
(**p < 0.01 versus control, n = 3). Data shown are
mean ± SEM.
(G) Current-clamp recording in small neurons
dissociated from rat DRGs showed that FSTL1
(30 nM) reduced the AP frequency triggered by
current injection and inducedmembrane hyperpo-
larization. Both effects were abolished by coap-
plied ouabain (OB, 100 mM, n = 7) or M3M4
peptide (10 mM, n = 6). Red lines indicate 60 mV.
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the a1 subunit.
The consequence of FSTL1-induced NKA activation was
further demonstrated in cultured small DRG neurons
(15–25 mm in diameter) by FSTL1-induced membrane hyperpo-
larization (7.6 ± 0.6mV, n = 7), reduced frequency of APs initiated
by depolarizing currents (Figure 5G), and prolonged afterhyper-
polarization (Figure S4G), which typically reduces AP firing (Pul-
ver and Griffith, 2010; Sah, 1996; Zhang et al., 2010). FSTL1E165A
did not induce such effects (Figure S4H). The FSTL1 actions
were abolished by ouabain, an NKA inhibitor (Kaplan, 2002)Neuron 69, 974–98which binds to the M4 and the M5–M6
hairpin of the a1 subunit (Qiu et al.,
2005) at a concentration of 100 mM (Fig-
ure 5G), but not at 1 mM (data not shown).
This effect is consistent with the lowerouabain sensitivity of a1NKA (Dobretsov et al., 1999a; Hamada
et al., 2003). FSTL1 actions were also antagonized by the pres-
ence of the M3M4 (Figure 5G), but not the M9M10 peptide
(data not shown). Thus, FSTL1-induced a1NKA activation regu-
lates both membrane potential and neuronal excitability.
FSTL1 Regulates Synaptic Transmission
by Activating NKA
The a1 subunit immunostaining was present in laminae I–IV of
the rodent spinal cord (Figure 6A and Figure S4I) and colocalized
with CGRP in afferent fibers in laminae I–II (Figure 6A). Such7, March 10, 2011 ª2011 Elsevier Inc. 981
Figure 6. FSTL1 Suppresses Synaptic
Transmission by Activating NKA
(A) Double immunostaining showed the a1 subunit
distribution in laminae I–IV of L4 segment of the rat
spinal cord and the colocalization of the a1 subunit
and CGRP in afferent fibers in laminae I–II. Four
days after the unilateral transaction of L1–6 dorsal
roots, the immunostaining patterns of the a1
subunit and CGRP were abolished. Scale bar =
100 mm.
(B) Double staining revealed FSTL1 localization in
a number of a1 subunit-positive axon terminals
(arrows) in lamina II. Stars indicate the cell body
of local neurons. Scale bar = 20 mm.
(C) Whole-cell recording in a rat spinal cord slice
showed that FSTL1 (60 nM)-induced suppressive
effect on sEPSCs of lamina II neurons was
reversed by ouabain (*p < 0.05; **p < 0.01 versus
control; ## p < 0.01, n = 5). Data shown are
mean ± SEM.
(D) Bath-applied M3M4 peptide (20 mM, 3 min)
increased the sEPSC frequency (*p < 0.05 versus
control, n = 6). Data shown are mean ± SEM.
(E) Recording from lamina II neurons showed that
3 min treatment of M3M4 peptide (20 mM)
increased the amplitude of EPSCs evoked by
C-fiber stimulation (*p < 0.05 versus control,
n = 5). Data shown are mean ± SEM.
(F) Proposed model of the FSTL1-a1NKA system
for regulating synaptic transmission. Membrane
depolarization triggers Ca2+-dependent exocy-
tosis of synaptic vesicles and FSTL1 vesicles.
Secreted FSTL1 directly activates the presynaptic
a1NKA to hyperpolarize the membrane (DVm)
and reduce Ca2+ influx, enabling an inhibitory
regulation of synaptic transmission. Discharged
synaptic vesicles are recycled and reloaded
with neurotransmitters at the axonal terminal,
whereas FSTL1 vesicles have to be recruited
from the soma. a1, a1 subunit of NKA; VDCC,
voltage-dependent Ca2+ channel; +, facilitation;,
suppression.
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which causes the degeneration of afferent fibers (Figure 6A).
Moreover, the a1 subunit mRNA was absent in the dorsal horn
neurons (Figure S4J), consistent with previous reports (Mata
et al., 1991). These data, together with the coexistence of
FSTL1 and the a1 subunit in many small DRG neurons and
a number of afferent terminals (Figures 4C and 6B), suggest
that a1NKA may act in afferent terminals as an autoreceptor
for the presynaptic action of FSTL1. The presence of axons con-
taining either the a1 subunit or the FSTL1 (Figure 6B) suggests
that a1NKA is also accessible to FSTL1 released from nearby
axons.
Further spinal cord slice recording showed that the reduction
of sEPSC frequency in lamina II neurons induced by exogenous
FSTL1 was reversed by 100 mM ouabain (Figure 6C). Perfusion
with the M3M4 peptide also increased sEPSC frequency
(Figure 6D) as well as C-fiber stimulation-induced eEPSC ampli-
tude (Figure 6E). Thus, afferent synaptic transmission is normally
suppressed by endogenously secreted FSTL1 through activa-
tion of a1NKA (Figure 6F).982 Neuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc.FSTL1 Is Required forMaintaining the Normal Threshold
of Somatic Sensation
Given that FSTL1-dependent a1NKA activity is required for
normal afferent synaptic transmission, we inquired whether
a reduction in FSTL1 resulted in sensory modification. Because
90% of FSTL1-containing DRG neurons expressed the
Nav1.8 channel, we made a conditional Fstl1 gene knockout
mouse by crossing a mouse with floxed alleles of the Fstl1
gene with a BAC transgenic mouse line expressing Cre re-
combinase controlled by promoter elements of the Nav1.8
gene (SNS-Cre) (Agarwal et al., 2004) (Figure 7A and Figure S5A).
In the Fstl1F/F:SNS-Cre (Fstl1/) mouse, FSTL1 was reduced in
small DRG neurons (Figures 7B and 7C) and their afferents in
spinal laminae I–II (Figure S5B), while the expression of the a1
subunit of NKA and other molecules did not change (Figure 7C).
The number of FSTL1-immunoractive vesicles in small DRG
neurons was also reduced in Fstl1/ mice (Figure S5C).
Whole-cell recording from FSTL1-sensitive lamina II neurons
showed that the baseline of sEPSC frequency in Fstl1/ mice
was elevated, and the K+ (15 mM KCl)-induced increase in
Figure 7. FSTL1 Is Required for Maintaining Normal Sensory Threshold
(A) PCR genotyping showed bands that correspond to heterozygote, Fstl1F/+ (399 and 505 bp), homozygote, Fstl1F/F (505 bp only), andwild-type animals, Fstl1+/+
(399 bp only).
(B) Immunoblotting of Fstl1+/+, Fstl1F/+:SNS-Cre (Fstl1+/) and Fstl1F/F:SNS-Cre (Fstl1/) DRGs showed a reduction of FSTL1 in Fstl1/ DRG tissue.
(C) In the DRG of Fstl1/mouse, the number of FSTL1-immunoreactive small neuronswasmarkedly reduced, while weak FSTL1 staining remained in some large
neurons. The expression of the NKA a1 subunit and several major molecules was not apparently altered. Scale bar = 100 mm.
(D) Whole-cell recording from lamina II neurons in spinal slices showed that the increase in sEPSC frequency induced by 15 mM KCl (1 min) is greater in Fstl1/
mice than in Fstl1+/+mice. Analysis was performed on neurons that respond to bath-applied FSTL1 (60 nM) in Fstl1/ (n = 18) and Fstl1+/+mice (n = 21) (*p < 0.05
versus Fstl1+/+ mice). Data shown are mean ± SEM.
(E) In vivo extracellular single-unit recording showed that WDR neurons in the spinal dorsal horn of Fstl1/mice (n = 6) were more sensitive to both thermal and
mechanical stimuli in the hindpaw (n = 6). Intrathecal injection (i.t.) of FSTL1 (2 mg) reversed the enhanced responses of WDR neurons in Fstl1+/+ mice (n = 3,
*p < 0.05, two-way ANOVA). Data shown are mean ± SEM.
(F) Both thermal and mechanical nociceptive responses were facilitated in Fstl1/ mice (**p < 0.01 versus Fstl1+/+ and Fstl1F/F mice, n = 12). Data shown are
mean ± SEM.
(G) FSTL1 (i.t.), but not FSTL1E165A, reduced the facilitated responses to noxious thermal stimuli in Fstl1/ mice (*p < 0.05; **p < 0.01 versus vehicle-treated
Fstl1/ mice, n = 8). Data shown are mean ± SEM.
(H) The increase in licking and lifting of the formalin (0.5%)-injected hindpaw in the first phase (Phase I) and the second phase (Phase II) of nociceptive responses
was more pronounced in Fstl1/ mice than control mice (*p < 0.05 versus Fstl1+/+ and Fstl1F/F mice, n = 6–8). Data shown are mean ± SEM.
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FSTL1 Activates Presynaptic Na+-K+ PumpsEPSC frequency in Fstl1/ mice was greater than the record-
ings from wild-type (Fstl1+/+) mice (Figure 7D). These results
were consistent with the suppressive action of FSTL1.
We performed in vivo extracellular recording of wide-dynamic-
range (WDR) neurons that make synaptic contacts with cuta-neous Ad-, C-, and Ab-fibers in spinal laminae III–V. These fibers
respond to both thermal and mechanical stimuli (Willis and Cog-
geshall, 2004). Stimulation of the receptive field of WDR neurons
on the plantar surface of the pawwith natural thermal ormechan-
ical stimuli (Urch and Dickenson, 2003) increased the AP firingNeuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc. 983
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FSTL1 Activates Presynaptic Na+-K+ Pumprate of WDR neurons in a stimulus-dependent manner (Fig-
ure 7E). The WDR neurons in Fstl1/ mice exhibited elevated
firing rates compared to Fstl1+/+ mice, enabling the same stim-
ulus to evoke a higher firing rate (Figure 7E). In Fstl1/ mice,
the firing rate induced by the innocuous stimuli (7.0 ± 1.5 Hz at
38C and 15.4 ± 1.8 Hz for pressure) was similar to the rate
induced by the noxious stimuli (7.9 ± 1.0 Hz at 45C and
16.3 ± 3.9 Hz for pinch) in Fstl1+/+ mice. Furthermore, FSTL1
applied to the dorsal spinal cord rescued these phenotypic
changes in Fstl1/ mice. FSTL1 reduced the firing rate of
WDR neurons to the rate found in Fstl1+/+ mice (Figure 7E),
thereby showing that hyperexcitability in Fstl1/mice is a direct
consequence of FSTL1 loss. As such, FSTL1 is essential for
maintaining the normal sensory threshold.
We further found that Fstl1/ mice exhibited reduced
response latencies during radiant heat testing (Figure 7F), indi-
cating exaggerated sensitivity to thermal nociceptive stimuli. In
the mechanical nociceptive test, the response threshold to von
Frey mechanical stimuli applied to the hindpaw was reduced in
Fstl1/ mice (Figure 7F). These behavioral changes were not
due to an overall increase in reactivity because Fstl1/ mice
did not have any apparent changes in open field tests or the
accelerating rotarod test (Figure S5D). The thermal hypersensi-
tivity in Fstl1/ mice was reversed with intrathecal injection of
FSTL1, but not FSTL1E165A (Figure 7G). Moreover, after intra-
dermal injection of 0.5% formalin, Fstl1/mice displayed exag-
gerated responses in both first and second phases of nocicep-
tive reaction (Figure 7H). Thus, FSTL1 contributes to the
mechanisms for suppressing afferent nociceptive transmission.
DISCUSSION
The present study revealed that the function of FSTL1 was to act
as an endogenous high-affinity agonist of a1NKA. Our results
further demonstrated that FSTL1 plays a role in regulating
synaptic transmission and the threshold of somatic sensation.
FSTL1 is secreted from sensory afferent axons and activates
presynaptic a1NKA, leading to membrane hyperpolarization
and suppression of neurotransmitter release (Figure 6F). Finding
an endogenous activator of NKA indicates that the Na+-K+ pump
can be rapidly regulated in vivo by secreted factors in an activity-
dependent manner. The loss of FSTL1-dependent NKA activa-
tion led to enhanced synaptic transmission and sensory hyper-
sensitivity. Therefore, the FSTL1-a1NKA system is essential for
the homeostatic regulation of somatic sensation.
Regulation of Synaptic Transmission by Follistatin Gene
Family Members
FSTL1 is one of the SPARC proteins in the follistatin gene family
(Brekken and Sage, 2000; Hambrock et al., 2004). However,
there is no evidence for functional similarity between FSTL1
and follistatin, which is an activin antagonist and functions during
development (Liem et al., 1997; Phillips and de Kretser, 1998).
We found that FSTL1, but not follistatin, suppressed synaptic
transmission. Moreover, FSTL1 lacks the conserved functions
of other SPARC proteins, which serve as matricellular proteins
to mediate cell-matrix interactions (Brekken and Sage, 2000;
Hambrock et al., 2004). We showed that FSTL1 suppressed984 Neuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc.the synapse by activating a1NKA. Interestingly, agrin (Patthy
and Nikolics, 1993), a member of the follistatin gene family, is
broadly expressed in the central nervous system (O’Connor
et al., 1994) and enhances neuronal excitation by inhibiting
a3NKA (Hilgenberg et al., 2006). It is possible that agrin and
FSTL1 provide bidirectional regulation of synaptic transmission
by regulating different isoforms of NKA. Such regulation could
be useful for homeostatic modulation of presynaptic neurotrans-
mitter release under different patterns of afferent activities.
Whether agrin secretion is activity dependent has yet to be
determined. Moreover, both the interaction between NKA and
receptors or channels in the presynaptic membrane and the
possibility of FSTL1 interaction with various factors in the
synaptic cleft may contribute to delicate mechanisms for regu-
lating synaptic activity.
FSTL1 Vesicle Represents a Subtype of Regulated
Secretory Vesicles
Both pre- and postembedding immunostaining showed the
vesicular localization of FSTL1 and their presynaptic distribution
in the afferent terminals. Identification of FSTL1-containing small
translucent vesicles provides insight into synaptic vesicle
biogenesis (Ferguson et al., 2007; Hannah et al., 1999; Santos
et al., 2009). Our results suggest that most FSTL1 protein is
not transported in the synaptoporin- and synapsin-containing
vesicles that mediate membrane transport from the TGN to the
plasma membrane (Hannah et al., 1999; Okada et al., 1995).
The presence of VAMP2 in FSTL1 vesicles suggests the exis-
tence of molecular machinery for exocytosis in these vesicles.
Glutamatergic synaptic vesicles are defined by their ability to
pack glutamate for secretion, a property conferred by the
expression of a VGluT (Daniels et al., 2006; Santos et al.,
2009). Therefore, the vesicles containing both FSTL1 and
VGluT2 might form a subset of glutamatergic vesicles in axon
terminals. So far, we could not determine the proportion of
FSTL1-containing vesicles in the afferent terminals because of
the limited sensitivity of immunoelectron microscopy. Based
on the findings of the FSTL1 vesicles and the stimulus-induced
FSTL1 secretion, which was similar to neuropeptides and gluta-
mate but different from the tenascin-C, we propose that a certain
number of FSTL1 vesicles could be stored in the axonal terminals
and secreted in response to stimulations.
FSTL1 Is a High-Affinity Activator of NKA
The notion that the a1 subunit of NKA serves as a FSTL1 receptor
is supported by several lines of evidence. First, both biochemical
and radioligand binding data showed high-affinity binding
between FSTL1 and the a1 subunit. Second, E314 in M3M4
and T889 in M7M8 of the a1 subunit were identified as critical
sites for FSTL1-binding. Third, FSTL1 elevated a1NKA activity
and induced membrane hyperpolarization. Fourth, these effects
could be attenuated by either inhibiting the a1NKA with 100 mM
ouabain or disrupting FSTL1-a1NKA binding with the M3M4
peptide. Finally, the loss of function of FSTL1E165A is due to its
failure to bind to the a1 subunit. Therefore FSTL1, but not
FSTL1E165A, reduced the speed of AP propagation through the
NKA-dependent membrane hyperpolarization, resulting in an
increased latency of eEPSC. Moreover, the finding that
Neuron
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produce a potent and stabilized effect supports a role for the
b subunit in the delivery and appropriate insertion of the a subunit
in the plasma membrane as well as a role in stabilizing the
enzyme (Kaplan, 2002). Thus, FSTL1 is an important endoge-
nously secreted protein that functions as an NKA agonist. It
would be interesting to know whether any other a isoform-
specific NKA agonists are expressed in various systems.
Specific FSTL1-binding sites were identified in M3M4 and
M7M8 of the a1 subunit. Blockade of FSTL1 interaction at either
EL was sufficient to attenuate FSTL1 action, suggesting that
simultaneous FSTL1-binding at both ELs is required. Involve-
ment of M7M8 in FSTL1 action suggests that M7M8 is still
accessible to the agonist, even if this EL is proposed to be
covered by the extracellular portion of the b subunit (Morth
et al., 2007). The FSTL1-binding sites are distinct from the
ouabain-binding sites in the M4 and the M5–M6 hairpin of the
a1 subunit (Qiu et al., 2005). Differences in the binding sites allow
ouabain to block FSTL1 action. However, analysis of the struc-
tural coordination between FSTL1 and a1NKA is needed to
better understand the mechanism of FSTL1 action.
Synaptic Transmission Is Regulated by an Endogenous
NKA Agonist
The present study showed that an endogenous agonist is critical
for normal activity of the Na+-K+ pump at sensory afferent
synapses in the dorsal spinal cord. Synaptic transmission was
enhanced by either attenuation of endogenous FSTL1 action
with ouabain and the M3M4 peptide or genetic deletion of
FSTL1. The facilitated synaptic transmission was attributed to
a reduction in both the FSTL1-induced tonic suppression of
nerve impulse propagation and the activity-induced Ca2+-influx,
which triggers the release of excitatory neurotransmitters. We
postulate that under physiological conditions, presynaptic
a1NKA would be tonically activated by spontaneously secreted
FSTL1. The elevation of neuronal activity would increase FSTL1
secretion to enhance a1NKA activity, enabling a homeostatic
regulation of synaptic transmission (Figure 6F). The physiological
activity of the Na+-K+ pump required an a isoform-specific
agonist released from neurons. The fact that relatively small
changes in the membrane potential contributed by modulation
of NKA activity resulted in marked synaptic effects (Scuri et al.,
2007) and sensory processing further underscores the active
role of NKA in neuronal function.
FSTL1-a1NKA System Is Essential for Normal Somatic
Sensation
The FSTL1 conditional knockout mice showed a reduced
threshold of somatic sensation and a hypersensitivity to noxious
stimulations. These phenotypic changes were reversed by
applying FSTL1, indicating that FSTL1 is a key regulator of
sensory transmission. FSTL1 is also required to suppress the
sensitization processes of inflammatory pain through both
peripheral and central mechanisms because Fstl1/ mice dis-
played an elevated response in both first and second phases
of the formalin test. Reduction in FSTL1-dependent homeostatic
regulation under pathological conditions, such as regulation
resulting from FSTL1 autoantibodies produced by human rheu-matoid arthritis (Tanaka et al., 2003), may contribute to abnormal
sensation. Moreover, low a1NKA activity is considered partly
responsible for the diabetic neuropathy that causes paresthesias
and pain (Krishnan and Kiernan, 2005). Therefore, we propose
that the FSTL1-a1NKA system is fundamental for maintaining
the threshold of somatic sensation in the physiological range
and dysfunction in this system leads to abnormal sensation
such as pain hypersensitivity.
EXPERIMENTAL PROCEDURES
Microarray, Northern Blotting, and In Situ Hybridization
The procedures are provided in the Supplemental Experimental Procedures.
Preparation of FSTL1-myc and His Fusion Protein
The cDNA encoding rat FSTL1 was obtained by RT-PCR and inserted into the
pcDNA 3.1/myc-His(-)A vector (see Supplemental Experimental Procedures).
Myc and His tags were fused at the C-terminal end. To verify the functional
specificity of recombinant FSTL1, we searched for loss-of-function FSTL1
mutants. FSTL1 contains a pair of EF-hands, which form the minimal stable
structural unit—a four-helix bundle domain. The most common EF-hand has
a 12- to 14-residue Ca2+-binding loop that started with Asp and ended with
Glu, the predicted Ca2+-binding site. We constructed FSTL1 mutants by
deleting EF-hands or inducing mutation at Glu165. The plasmids were trans-
fected into HEK293T cells. After 12 hr incubation, DMEM containing 10%
FBS was replaced by Iscove’s medium. The supernatant was collected every
48 hr and purified on Ni2+ beads.
Preparation of FSTL1 Antibodies
The cDNA encoding 31 amino acids of the C terminus or full-length rat FSTL1
was obtained by RT-PCR and inserted into the pGEX-KG vector (see Supple-
mental Experimental Procedures). Inducible expression and purification of the
recombinant proteins were carried out with the GST gene fusion system. The
antibody preparation and specificity tests are described in the Supplemental
Experimental Procedures.
Isolation of Vesicles and Immunoblotting
The preparation of vesicles from synaptosomes and immunoblotting are
described in the Supplemental Experimental Procedures.
Analysis of Secretion
Levels of secreted FSTL1, CGRP, tenascin-C, SP, and glutamate were
measured with immunoblotting, immunoassay, radioimmunoassay, or HPLC
methods, respectively (see Supplemental Experimental Procedures).
Immunostaining
Cryostat sections of lumbar (L) 4–5 DRGs and spinal segments were
immunostained. Postembedding immunogold labeling and pre-embedding
immunoperoxidase staining were performed. To distinguish the immunoper-
oxidase-labeled vesicles from unlabeled ones, we did not counterstain ultra-
thin sections with uranyl acetate and lead citrate. For axon immunostaining,
the axons from L4–5 dorsal roots were fixed in 20C methanol and double
immunostained. The procedures are provided in the Supplemental Experi-
mental Procedures.
Cell Culture and Transfection
COS7 cells were cultured in DMEM containing 10% FBS. The cells were trans-
fected with 1 mg plasmid and 10 ml Lipofectin Reagent (GIBCO) (30 mm dish) in
serum-freemedium for 6 hr and then inmedium containing serum for 2–3 days.
Biochemistry
Neurons cultured from 60DRGswere preincubated with FSTL1 for 30min, and
then stabilized with membrane-impermeant BS3 (Pierce) for 60 min (see
Supplemental Experimental Procedures). The cells were processed for immu-
noblotting or MS analysis (see Supplemental Experimental Procedures).Neuron 69, 974–987, March 10, 2011 ª2011 Elsevier Inc. 985
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The DRGs or COS7 cells were lysed and processed for immunoprecipitation
and immunoblotting (see Supplemental Experimental Procedures).
Na+,K+-ATPase Assay
COS7 cells expressing NKA subunits or mutants and cultured DRG neurons
were treated with FSTL1 for 30 min. The NKA activity, which is the difference
between total ATPase activity and ouabain-insensitive Mg2+-ATPase activity
(Esmann, 1988), was measured in the cell lysate (see Supplemental Experi-
mental Procedures). The effect of FSTL1 was also studied with the NKA puri-
fied from the rat spinal cord (see Supplemental Experimental Procedures).
Equilibrium Binding Assay
The binding of 125I-FSTL1 to the transfected COS7 cells was measured (see
Supplemental Experimental Procedures).
BIAcore Immobilization and Analysis
The binding assay was performed by injecting synthetic peptides correspond-
ing to each EL of the a1 subunit with a series of concentrations over the
recombinant FSTL1 immobilized onto the sensor chip (Pharmacia BIAcore)
(see Supplemental Experimental Procedures).
Generation of Fstl1-Deficient Mouse
The procedure for generating the conditional Fstl1 knockout mice is given in
the Supplemental Experimental Procedures.
Whole-Cell Patch Clamp Recording
Transverse spinal cord slices with an attached dorsal root from adult rats were
prepared for blind whole-cell recording (see Supplemental Experimental
Procedures). Dorsal root stimulation, which recruits Ad- and C-fibers, was
delivered with a suction electrode. Monosynaptic and polysynaptic eEPSCs
were studied in the presence of 20 mMbicuculline and 2 mM strychnine (Nakat-
suka et al., 2000). Current-clamp recording was performed in dissociated DRG
neurons (see Supplemental Experimental Procedures).
Extracellular Single-Unit Recording of WDR Neurons
The procedure of recording in anesthetized Fstl1+/+ and Fstl1/ male mice is
provided in Supplemental Experimental Procedures.
Behavioral Tests
Experiments were carried out following the guidelines of the International
Association for the Study of Pain and approved by the Institute of Neurosci-
ence, Chinese Academy of Sciences. The sensitivity of mouse hindpaw to
heat or mechanical stimuli was measured. The accelerating rotarod and the
open field tests were performed. Formalin (0.5%, 20 ml) was injected into the
dorsal surface of the left hindpaw of mice. The licking and lifting time of the in-
jected hindpaw during each 5 min interval for 1 hr after injection was recorded.
The procedures are given in Supplemental Experimental Procedures.
Statistical Analysis
Statistical analysis was performed using PRISM (GraphPad Software). Two
groups were evaluated by Student’s t test. Comparisons among multiple
groups were performed by using two-way ANOVA, followed by a two-tailed,
unpaired Student’s t test for between group comparisons. Differences were
considered significant at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2011.01.022.
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